

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.02915930 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.63157831 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.42632147 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.42632147 |
| 5 | negative T cell selection (GO:0043383) | 5.25993084 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 5.22316286 |
| 7 | positive thymic T cell selection (GO:0045059) | 5.21411621 |
| 8 | negative thymic T cell selection (GO:0045060) | 5.14996149 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.09406744 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.09406744 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.87857182 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.86868375 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.85333094 |
| 14 | mannose metabolic process (GO:0006013) | 4.76419715 |
| 15 | negative regulation of granulocyte differentiation (GO:0030853) | 4.72303814 |
| 16 | positive T cell selection (GO:0043368) | 4.43144123 |
| 17 | positive regulation of B cell differentiation (GO:0045579) | 4.41204789 |
| 18 | leukocyte aggregation (GO:0070486) | 4.35316543 |
| 19 | thymic T cell selection (GO:0045061) | 4.31726762 |
| 20 | regulation of skeletal muscle contraction (GO:0014819) | 4.31218878 |
| 21 | B cell receptor signaling pathway (GO:0050853) | 4.30530425 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.22132583 |
| 23 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.12003503 |
| 24 | T cell selection (GO:0045058) | 4.08595633 |
| 25 | regulation of B cell differentiation (GO:0045577) | 4.07221411 |
| 26 | adenosine receptor signaling pathway (GO:0001973) | 3.95679973 |
| 27 | regulation of histone H3-K27 methylation (GO:0061085) | 3.93187837 |
| 28 | mast cell activation (GO:0045576) | 3.91914795 |
| 29 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.86455547 |
| 30 | regulation of granulocyte differentiation (GO:0030852) | 3.69737377 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.67780741 |
| 32 | low-density lipoprotein particle clearance (GO:0034383) | 3.67763191 |
| 33 | mature B cell differentiation (GO:0002335) | 3.63089207 |
| 34 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.62576629 |
| 35 | T cell homeostasis (GO:0043029) | 3.57998450 |
| 36 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.55024119 |
| 37 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.51196943 |
| 38 | response to interleukin-15 (GO:0070672) | 3.49687862 |
| 39 | Peyers patch development (GO:0048541) | 3.48827290 |
| 40 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.48827290 |
| 41 | T cell receptor signaling pathway (GO:0050852) | 3.47760587 |
| 42 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.47494680 |
| 43 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.46459791 |
| 44 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.44414095 |
| 45 | ribosomal small subunit assembly (GO:0000028) | 3.43745797 |
| 46 | * interferon-gamma production (GO:0032609) | 3.41578809 |
| 47 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.41323846 |
| 48 | T cell costimulation (GO:0031295) | 3.40047125 |
| 49 | T cell migration (GO:0072678) | 3.38311691 |
| 50 | lymphocyte costimulation (GO:0031294) | 3.36131332 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.35740480 |
| 52 | tolerance induction (GO:0002507) | 3.33504814 |
| 53 | regulation of sequestering of triglyceride (GO:0010889) | 3.28104012 |
| 54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.27904591 |
| 55 | activated T cell proliferation (GO:0050798) | 3.26747511 |
| 56 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.23216349 |
| 57 | positive regulation of granulocyte differentiation (GO:0030854) | 3.23067063 |
| 58 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.22703155 |
| 59 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.21785948 |
| 60 | response to peptidoglycan (GO:0032494) | 3.19051398 |
| 61 | fatty acid transmembrane transport (GO:1902001) | 3.19018197 |
| 62 | viral transcription (GO:0019083) | 3.18310903 |
| 63 | cellular response to interleukin-15 (GO:0071350) | 3.17335662 |
| 64 | leukocyte cell-cell adhesion (GO:0007159) | 3.14180230 |
| 65 | carnitine shuttle (GO:0006853) | 3.11843420 |
| 66 | cellular response to epinephrine stimulus (GO:0071872) | 3.11641999 |
| 67 | negative regulation of phagocytosis (GO:0050765) | 3.11434576 |
| 68 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.10386615 |
| 69 | germinal center formation (GO:0002467) | 3.09848659 |
| 70 | lymphocyte homeostasis (GO:0002260) | 3.09223708 |
| 71 | regulation of T cell tolerance induction (GO:0002664) | 3.08078061 |
| 72 | positive regulation of lamellipodium assembly (GO:0010592) | 3.06555041 |
| 73 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.04011809 |
| 74 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.04011809 |
| 75 | translational termination (GO:0006415) | 3.00243769 |
| 76 | positive regulation of isotype switching (GO:0045830) | 2.99738959 |
| 77 | purinergic receptor signaling pathway (GO:0035587) | 2.95793882 |
| 78 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.94491251 |
| 79 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.93618524 |
| 80 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.91749011 |
| 81 | mast cell degranulation (GO:0043303) | 2.91101455 |
| 82 | mast cell activation involved in immune response (GO:0002279) | 2.91101455 |
| 83 | B cell mediated immunity (GO:0019724) | 2.90350462 |
| 84 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90128768 |
| 85 | B cell homeostasis (GO:0001782) | 2.89183754 |
| 86 | cellular extravasation (GO:0045123) | 2.89069799 |
| 87 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.88296076 |
| 88 | T cell proliferation (GO:0042098) | 2.86978839 |
| 89 | negative regulation of interleukin-8 production (GO:0032717) | 2.86976297 |
| 90 | leukocyte homeostasis (GO:0001776) | 2.86246030 |
| 91 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.85666614 |
| 92 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.85567839 |
| 93 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.84039630 |
| 94 | definitive hemopoiesis (GO:0060216) | 2.83683694 |
| 95 | regulation of regulatory T cell differentiation (GO:0045589) | 2.83144439 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83137658 |
| 97 | defense response to protozoan (GO:0042832) | 2.82827578 |
| 98 | triglyceride catabolic process (GO:0019433) | 2.80668620 |
| 99 | cellular defense response (GO:0006968) | 2.80488214 |
| 100 | positive regulation of interleukin-2 production (GO:0032743) | 2.78845269 |
| 101 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.78351871 |
| 102 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.78351871 |
| 103 | response to protozoan (GO:0001562) | 2.73967111 |
| 104 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.73269586 |
| 105 | lymph node development (GO:0048535) | 2.72595075 |
| 106 | polyol transport (GO:0015791) | 2.71545270 |
| 107 | NIK/NF-kappaB signaling (GO:0038061) | 2.70378404 |
| 108 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.69673006 |
| 109 | myeloid dendritic cell activation (GO:0001773) | 2.69596565 |
| 110 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68193737 |
| 111 | response to mercury ion (GO:0046689) | 2.67116193 |
| 112 | positive regulation of B cell activation (GO:0050871) | 2.65971456 |
| 113 | positive regulation of B cell mediated immunity (GO:0002714) | 2.65179936 |
| 114 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.65179936 |
| 115 | phospholipid scrambling (GO:0017121) | 2.64843149 |
| 116 | * excretion (GO:0007588) | 2.63744348 |
| 117 | valine metabolic process (GO:0006573) | 2.63486655 |
| 118 | urate metabolic process (GO:0046415) | 2.62943870 |
| 119 | positive regulation of tolerance induction (GO:0002645) | 2.62483302 |
| 120 | negative regulation of T cell mediated immunity (GO:0002710) | 2.61477964 |
| 121 | diacylglycerol metabolic process (GO:0046339) | 2.61424682 |
| 122 | establishment of endothelial barrier (GO:0061028) | 2.60599693 |
| 123 | T cell differentiation (GO:0030217) | 2.60133307 |
| 124 | mature B cell differentiation involved in immune response (GO:0002313) | 2.59505165 |
| 125 | ribosomal small subunit biogenesis (GO:0042274) | 2.58837595 |
| 126 | positive regulation of DNA recombination (GO:0045911) | 2.58673630 |
| 127 | hepatocyte apoptotic process (GO:0097284) | 2.58503384 |
| 128 | megakaryocyte development (GO:0035855) | 2.57700888 |
| 129 | respiratory burst (GO:0045730) | 2.57653954 |
| 130 | positive regulation of Rap GTPase activity (GO:0032854) | 2.56997299 |
| 131 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.56207137 |
| 132 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.56137626 |
| 133 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.54688233 |
| 134 | regulation of tumor necrosis factor production (GO:0032680) | 2.53769609 |
| 135 | detection of other organism (GO:0098543) | 2.49831965 |
| 136 | cGMP-mediated signaling (GO:0019934) | 2.48932229 |
| 137 | macrophage activation involved in immune response (GO:0002281) | 2.48907127 |
| 138 | histone H3-K36 demethylation (GO:0070544) | 2.48900935 |
| 139 | negative regulation of myotube differentiation (GO:0010832) | 2.48839477 |
| 140 | cAMP biosynthetic process (GO:0006171) | 2.48129699 |
| 141 | negative regulation of innate immune response (GO:0045824) | 2.47596815 |
| 142 | regulation of necroptotic process (GO:0060544) | 2.47506489 |
| 143 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.45612592 |
| 144 | neutrophil activation involved in immune response (GO:0002283) | 2.44988489 |
| 145 | response to epinephrine (GO:0071871) | 2.44650373 |
| 146 | apoptotic process involved in morphogenesis (GO:0060561) | 2.42759751 |
| 147 | activation of protein kinase A activity (GO:0034199) | 2.41118311 |
| 148 | acylglycerol catabolic process (GO:0046464) | 2.40569826 |
| 149 | neutral lipid catabolic process (GO:0046461) | 2.40569826 |
| 150 | detection of bacterium (GO:0016045) | 2.40265776 |
| 151 | positive regulation of protein kinase C signaling (GO:0090037) | 2.39512422 |
| 152 | stress fiber assembly (GO:0043149) | 2.38382174 |
| 153 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.37875503 |
| 154 | lymphocyte migration (GO:0072676) | 2.36240854 |
| 155 | skeletal muscle adaptation (GO:0043501) | 2.34138522 |
| 156 | regulation of protein kinase A signaling (GO:0010738) | 2.33359664 |
| 157 | carnitine transmembrane transport (GO:1902603) | 2.30526069 |
| 158 | myeloid cell activation involved in immune response (GO:0002275) | 2.30387704 |
| 159 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.29911098 |
| 160 | lipid storage (GO:0019915) | 2.29673649 |
| 161 | positive regulation of cholesterol efflux (GO:0010875) | 2.28830776 |
| 162 | regulation of germinal center formation (GO:0002634) | 2.28026352 |
| 163 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.27524731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.45349938 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.44068661 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.24905951 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.09299251 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.49511304 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.46279650 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.30717471 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.98190684 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.83466768 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.78697688 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.78654256 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.72690823 |
| 13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.69701798 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.68547242 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.66908404 |
| 16 | * MAF_26560356_Chip-Seq_TH1_Human | 2.63109462 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.57248760 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.54807857 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53203527 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.52706683 |
| 21 | * MYB_26560356_Chip-Seq_TH1_Human | 2.50991048 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49989331 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48296554 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.47412532 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44727756 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41120135 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.40371742 |
| 28 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.39091084 |
| 29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37616853 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.36599940 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31968758 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14188675 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.06065136 |
| 34 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.03456278 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00700290 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98623196 |
| 37 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97866092 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.94004494 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92425249 |
| 40 | P68_20966046_ChIP-Seq_HELA_Human | 1.84812108 |
| 41 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.81330455 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.80132206 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78376404 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77362137 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76652982 |
| 46 | * MAF_26560356_Chip-Seq_TH2_Human | 1.72177442 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.71625827 |
| 48 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.70136914 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.69977304 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.69223746 |
| 51 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67525716 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.65886357 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65688505 |
| 54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63013917 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60953368 |
| 56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.60712205 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55692811 |
| 58 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.54989372 |
| 59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54053796 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53632517 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.52331541 |
| 62 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50226309 |
| 63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.47758604 |
| 64 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.45920842 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45644103 |
| 66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.44466993 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43206735 |
| 68 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.42979959 |
| 69 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.41622394 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41390337 |
| 71 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41137125 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.40393762 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40316819 |
| 74 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38125590 |
| 75 | KDM2B_26808549_Chip-Seq_K562_Human | 1.36111041 |
| 76 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.32953552 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32702703 |
| 78 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.32312322 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28705750 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27803454 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27793412 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26077059 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25983846 |
| 84 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25686448 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23500713 |
| 86 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.23164429 |
| 87 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22114538 |
| 88 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21854314 |
| 89 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21605083 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21459326 |
| 91 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.20811299 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20741898 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20521871 |
| 94 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.19913216 |
| 95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18793316 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17746547 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17642570 |
| 98 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17437948 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17431604 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13933707 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13081234 |
| 102 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.12365492 |
| 103 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11740598 |
| 104 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.11031330 |
| 105 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09908581 |
| 106 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09753762 |
| 107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08471546 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08277612 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07116409 |
| 110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07114220 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06830357 |
| 112 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.06012797 |
| 113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05663548 |
| 114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03788909 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03305662 |
| 116 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00595303 |
| 117 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.00575633 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99859634 |
| 119 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99594629 |
| 120 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.99463860 |
| 121 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99392055 |
| 122 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.99384203 |
| 123 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97264018 |
| 124 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97000911 |
| 125 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94040910 |
| 126 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.92194027 |
| 127 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.87722740 |
| 128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87425163 |
| 129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86793429 |
| 130 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85302052 |
| 131 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.85003013 |
| 132 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83825841 |
| 133 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.81898160 |
| 134 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81203040 |
| 135 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80668265 |
| 136 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80589099 |
| 137 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.79293032 |
| 138 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.78524129 |
| 139 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78366831 |
| 140 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77777882 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77335910 |
| 142 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77024154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.52927969 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.48964902 |
| 3 | MP0005671_abnormal_response_to | 3.28489355 |
| 4 | MP0000685_abnormal_immune_system | 3.21544950 |
| 5 | MP0004130_abnormal_muscle_cell | 3.19471205 |
| 6 | MP0001800_abnormal_humoral_immune | 3.07820941 |
| 7 | MP0000751_myopathy | 3.01524054 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.93995566 |
| 9 | MP0005666_abnormal_adipose_tissue | 2.86137047 |
| 10 | MP0001790_abnormal_immune_system | 2.85722824 |
| 11 | MP0005387_immune_system_phenotype | 2.85722824 |
| 12 | MP0001986_abnormal_taste_sensitivity | 2.75434058 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.68605129 |
| 14 | MP0005670_abnormal_white_adipose | 2.66504349 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.64740713 |
| 16 | MP0003436_decreased_susceptibility_to | 2.61399938 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.57742214 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.56898337 |
| 19 | MP0002398_abnormal_bone_marrow | 2.56226136 |
| 20 | MP0002723_abnormal_immune_serum | 2.54681264 |
| 21 | MP0001819_abnormal_immune_cell | 2.53297206 |
| 22 | MP0003828_pulmonary_edema | 2.49190020 |
| 23 | MP0004043_abnormal_pH_regulation | 2.41157946 |
| 24 | MP0005025_abnormal_response_to | 2.32478446 |
| 25 | MP0004185_abnormal_adipocyte_glucose | 2.31819037 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.26170593 |
| 27 | MP0000716_abnormal_immune_system | 2.26133067 |
| 28 | MP0005174_abnormal_tail_pigmentation | 2.23611550 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.22385346 |
| 30 | MP0009785_altered_susceptibility_to | 2.21055231 |
| 31 | MP0005375_adipose_tissue_phenotype | 2.19193893 |
| 32 | MP0005409_darkened_coat_color | 2.13698309 |
| 33 | MP0002722_abnormal_immune_system | 2.09282400 |
| 34 | MP0002419_abnormal_innate_immunity | 2.05437546 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 2.03008097 |
| 36 | MP0001873_stomach_inflammation | 2.02490784 |
| 37 | MP0005451_abnormal_body_composition | 2.00759665 |
| 38 | MP0002006_tumorigenesis | 2.00054081 |
| 39 | MP0000703_abnormal_thymus_morphology | 1.99075771 |
| 40 | MP0003303_peritoneal_inflammation | 1.96708445 |
| 41 | * MP0002429_abnormal_blood_cell | 1.95991068 |
| 42 | MP0001661_extended_life_span | 1.93731236 |
| 43 | MP0002148_abnormal_hypersensitivity_rea | 1.89905719 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.89198599 |
| 45 | MP0002405_respiratory_system_inflammati | 1.87086239 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.81632253 |
| 47 | MP0004808_abnormal_hematopoietic_stem | 1.80723693 |
| 48 | MP0003866_abnormal_defecation | 1.74771967 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.72338327 |
| 50 | MP0002971_abnormal_brown_adipose | 1.72139930 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.66474041 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.66073538 |
| 53 | MP0003724_increased_susceptibility_to | 1.63768257 |
| 54 | * MP0002136_abnormal_kidney_physiology | 1.58350380 |
| 55 | MP0002638_abnormal_pupillary_reflex | 1.58268427 |
| 56 | MP0006138_congestive_heart_failure | 1.56915123 |
| 57 | MP0005423_abnormal_somatic_nervous | 1.55653293 |
| 58 | MP0009115_abnormal_fat_cell | 1.55045831 |
| 59 | MP0004087_abnormal_muscle_fiber | 1.52939738 |
| 60 | MP0004947_skin_inflammation | 1.52410317 |
| 61 | MP0000747_muscle_weakness | 1.51273737 |
| 62 | MP0005360_urolithiasis | 1.49994605 |
| 63 | MP0006082_CNS_inflammation | 1.49972579 |
| 64 | * MP0009643_abnormal_urine_homeostasis | 1.49821362 |
| 65 | MP0001853_heart_inflammation | 1.49690477 |
| 66 | MP0000003_abnormal_adipose_tissue | 1.49321497 |
| 67 | * MP0001756_abnormal_urination | 1.46289926 |
| 68 | MP0000490_abnormal_crypts_of | 1.46071539 |
| 69 | MP0005171_absent_coat_pigmentation | 1.45616679 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.44434613 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 1.44434613 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.44288947 |
| 73 | MP0003195_calcinosis | 1.43109576 |
| 74 | MP0005076_abnormal_cell_differentiation | 1.39789436 |
| 75 | MP0009278_abnormal_bone_marrow | 1.37526505 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.36595951 |
| 77 | MP0000759_abnormal_skeletal_muscle | 1.36506448 |
| 78 | MP0002332_abnormal_exercise_endurance | 1.36410904 |
| 79 | * MP0001765_abnormal_ion_homeostasis | 1.35828481 |
| 80 | MP0008469_abnormal_protein_level | 1.34892221 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 1.34696891 |
| 82 | MP0002933_joint_inflammation | 1.33906020 |
| 83 | MP0005058_abnormal_lysosome_morphology | 1.33637356 |
| 84 | MP0003172_abnormal_lysosome_physiology | 1.33494909 |
| 85 | MP0005330_cardiomyopathy | 1.29537371 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 1.28910673 |
| 87 | MP0000750_abnormal_muscle_regeneration | 1.27495411 |
| 88 | MP0003690_abnormal_glial_cell | 1.26578796 |
| 89 | MP0003646_muscle_fatigue | 1.26150322 |
| 90 | MP0002009_preneoplasia | 1.26053347 |
| 91 | MP0005334_abnormal_fat_pad | 1.26013433 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 1.25757473 |
| 93 | MP0004084_abnormal_cardiac_muscle | 1.25579388 |
| 94 | MP0000858_altered_metastatic_potential | 1.21235357 |
| 95 | MP0000569_abnormal_digit_pigmentation | 1.20803561 |
| 96 | MP0002095_abnormal_skin_pigmentation | 1.18703437 |
| 97 | MP0005535_abnormal_body_temperature | 1.15435153 |
| 98 | MP0002970_abnormal_white_adipose | 1.14855909 |
| 99 | MP0008961_abnormal_basal_metabolism | 1.11647901 |
| 100 | MP0003091_abnormal_cell_migration | 1.11126226 |
| 101 | MP0004381_abnormal_hair_follicle | 1.10805378 |
| 102 | MP0004036_abnormal_muscle_relaxation | 1.09468759 |
| 103 | MP0010630_abnormal_cardiac_muscle | 1.09128582 |
| 104 | MP0005332_abnormal_amino_acid | 1.08102931 |
| 105 | * MP0005636_abnormal_mineral_homeostasis | 1.06554804 |
| 106 | MP0000749_muscle_degeneration | 1.05889107 |
| 107 | MP0000249_abnormal_blood_vessel | 1.05874155 |
| 108 | MP0001533_abnormal_skeleton_physiology | 1.05393111 |
| 109 | MP0004484_altered_response_of | 1.05135163 |
| 110 | MP0002019_abnormal_tumor_incidence | 1.00879149 |
| 111 | MP0002106_abnormal_muscle_physiology | 0.98668168 |
| 112 | MP0003279_aneurysm | 0.97463477 |
| 113 | MP0008260_abnormal_autophagy | 0.94954034 |
| 114 | MP0004215_abnormal_myocardial_fiber | 0.94937146 |
| 115 | MP0003191_abnormal_cellular_cholesterol | 0.94588218 |
| 116 | MP0009764_decreased_sensitivity_to | 0.94061458 |
| 117 | MP0005310_abnormal_salivary_gland | 0.93129389 |
| 118 | MP0010094_abnormal_chromosome_stability | 0.91803212 |
| 119 | MP0001544_abnormal_cardiovascular_syste | 0.89775799 |
| 120 | MP0005385_cardiovascular_system_phenoty | 0.89775799 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.89722992 |
| 122 | MP0003448_altered_tumor_morphology | 0.89567797 |
| 123 | MP0003959_abnormal_lean_body | 0.88162474 |
| 124 | MP0002928_abnormal_bile_duct | 0.87815569 |
| 125 | MP0003183_abnormal_peptide_metabolism | 0.86729240 |
| 126 | MP0000371_diluted_coat_color | 0.85666897 |
| 127 | MP0004510_myositis | 0.80976498 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79949238 |
| 129 | MP0001663_abnormal_digestive_system | 0.74520565 |
| 130 | MP0003077_abnormal_cell_cycle | 0.73895787 |
| 131 | MP0001851_eye_inflammation | 0.73407234 |
| 132 | MP0009763_increased_sensitivity_to | 0.72925889 |
| 133 | MP0003656_abnormal_erythrocyte_physiolo | 0.70616373 |
| 134 | MP0008057_abnormal_DNA_replication | 0.69200745 |
| 135 | * MP0002135_abnormal_kidney_morphology | 0.68424830 |
| 136 | MP0008007_abnormal_cellular_replicative | 0.68307091 |
| 137 | MP0003693_abnormal_embryo_hatching | 0.67601920 |
| 138 | MP0008058_abnormal_DNA_repair | 0.66700679 |
| 139 | MP0002998_abnormal_bone_remodeling | 0.66417833 |
| 140 | MP0001958_emphysema | 0.66303561 |
| 141 | MP0003943_abnormal_hepatobiliary_system | 0.65142591 |
| 142 | MP0009765_abnormal_xenobiotic_induced | 0.62732506 |
| 143 | MP0002075_abnormal_coat/hair_pigmentati | 0.60044221 |
| 144 | MP0000609_abnormal_liver_physiology | 0.59273859 |
| 145 | MP0000313_abnormal_cell_death | 0.58872865 |
| 146 | MP0004019_abnormal_vitamin_homeostasis | 0.57956431 |
| 147 | MP0000477_abnormal_intestine_morphology | 0.56557765 |
| 148 | MP0003795_abnormal_bone_structure | 0.56143107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 7.27334096 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 5.98620234 |
| 3 | Abnormality of chloride homeostasis (HP:0011422) | 5.77855858 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 5.72323420 |
| 5 | Increased circulating renin level (HP:0000848) | 4.66921995 |
| 6 | * Polyuria (HP:0000103) | 4.66872727 |
| 7 | Hypomagnesemia (HP:0002917) | 4.65837452 |
| 8 | IgM deficiency (HP:0002850) | 4.60814295 |
| 9 | Hyperaldosteronism (HP:0000859) | 4.44342474 |
| 10 | * Abnormal urine output (HP:0012590) | 4.22526382 |
| 11 | Renal salt wasting (HP:0000127) | 3.99792962 |
| 12 | Alkalosis (HP:0001948) | 3.95257430 |
| 13 | Abnormality of magnesium homeostasis (HP:0004921) | 3.89542601 |
| 14 | Tetany (HP:0001281) | 3.85242132 |
| 15 | T lymphocytopenia (HP:0005403) | 3.81563454 |
| 16 | Recurrent viral infections (HP:0004429) | 3.77676435 |
| 17 | * Abnormality of renal excretion (HP:0011036) | 3.67607843 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.66434711 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.60103500 |
| 20 | Hemorrhage of the eye (HP:0011885) | 3.59995333 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.58205126 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.49498957 |
| 23 | Annular pancreas (HP:0001734) | 3.46211133 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 3.37720952 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.36559114 |
| 26 | Panhypogammaglobulinemia (HP:0003139) | 3.32711327 |
| 27 | Exercise-induced myalgia (HP:0003738) | 3.30112576 |
| 28 | Agammaglobulinemia (HP:0004432) | 3.22039480 |
| 29 | * Abnormal drinking behavior (HP:0030082) | 3.20282395 |
| 30 | * Polydipsia (HP:0001959) | 3.20282395 |
| 31 | Muscle fiber splitting (HP:0003555) | 3.19707965 |
| 32 | Distal lower limb muscle weakness (HP:0009053) | 3.16350591 |
| 33 | Abnormality of the fingertips (HP:0001211) | 3.10190623 |
| 34 | Eczematoid dermatitis (HP:0000976) | 3.09810743 |
| 35 | Recurrent bronchitis (HP:0002837) | 3.09225030 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 3.07269778 |
| 37 | Thin bony cortex (HP:0002753) | 3.03866596 |
| 38 | Slow saccadic eye movements (HP:0000514) | 3.03777745 |
| 39 | Chronic otitis media (HP:0000389) | 3.02331962 |
| 40 | * Abnormality of renin-angiotensin system (HP:0000847) | 3.01075688 |
| 41 | Abnormality of T cells (HP:0002843) | 2.98892386 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 2.96940578 |
| 43 | Difficulty running (HP:0009046) | 2.95808831 |
| 44 | IgG deficiency (HP:0004315) | 2.95177833 |
| 45 | Inflammation of the large intestine (HP:0002037) | 2.92381654 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.88180691 |
| 47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.88180691 |
| 48 | Hypertriglyceridemia (HP:0002155) | 2.83753778 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.82419058 |
| 50 | Stomatitis (HP:0010280) | 2.82405926 |
| 51 | Meningitis (HP:0001287) | 2.81018532 |
| 52 | Colitis (HP:0002583) | 2.77683611 |
| 53 | Hypokalemia (HP:0002900) | 2.77480517 |
| 54 | Reticulocytopenia (HP:0001896) | 2.75894996 |
| 55 | Gastrointestinal stroma tumor (HP:0100723) | 2.71381102 |
| 56 | Impaired platelet aggregation (HP:0003540) | 2.70640303 |
| 57 | Abnormal platelet function (HP:0011869) | 2.70640303 |
| 58 | Increased connective tissue (HP:0009025) | 2.68937034 |
| 59 | Pustule (HP:0200039) | 2.67509756 |
| 60 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.67307276 |
| 61 | Gout (HP:0001997) | 2.65516351 |
| 62 | Intestinal fistula (HP:0100819) | 2.64475343 |
| 63 | Facial diplegia (HP:0001349) | 2.64274518 |
| 64 | Lymphopenia (HP:0001888) | 2.62778607 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.62376341 |
| 66 | B lymphocytopenia (HP:0010976) | 2.62376341 |
| 67 | Papilloma (HP:0012740) | 2.60882087 |
| 68 | Verrucae (HP:0200043) | 2.60882087 |
| 69 | Severe combined immunodeficiency (HP:0004430) | 2.57774012 |
| 70 | Thrombocytosis (HP:0001894) | 2.56505853 |
| 71 | Cellulitis (HP:0100658) | 2.56229550 |
| 72 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.55667757 |
| 73 | Increased variability in muscle fiber diameter (HP:0003557) | 2.55575940 |
| 74 | Recurrent skin infections (HP:0001581) | 2.54731220 |
| 75 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.51114473 |
| 76 | Short chin (HP:0000331) | 2.49709267 |
| 77 | Myositis (HP:0100614) | 2.49497546 |
| 78 | Thyroiditis (HP:0100646) | 2.48219888 |
| 79 | Anteriorly placed anus (HP:0001545) | 2.47673838 |
| 80 | Eosinophilia (HP:0001880) | 2.47487315 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 2.46645782 |
| 82 | Testicular atrophy (HP:0000029) | 2.46609841 |
| 83 | Progressive muscle weakness (HP:0003323) | 2.44347997 |
| 84 | Combined immunodeficiency (HP:0005387) | 2.42759073 |
| 85 | Chronic diarrhea (HP:0002028) | 2.41974309 |
| 86 | Gastrointestinal infarctions (HP:0005244) | 2.38387235 |
| 87 | Mediastinal lymphadenopathy (HP:0100721) | 2.37998985 |
| 88 | Petechiae (HP:0000967) | 2.34067809 |
| 89 | Vasculitis (HP:0002633) | 2.33313480 |
| 90 | Easy fatigability (HP:0003388) | 2.33115853 |
| 91 | EMG: myopathic abnormalities (HP:0003458) | 2.30449530 |
| 92 | Turricephaly (HP:0000262) | 2.30317048 |
| 93 | Obstructive sleep apnea (HP:0002870) | 2.30013012 |
| 94 | Abnormality of eosinophils (HP:0001879) | 2.29906823 |
| 95 | Joint hemorrhage (HP:0005261) | 2.29715874 |
| 96 | * Abnormality of sodium homeostasis (HP:0010931) | 2.29564758 |
| 97 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.29342854 |
| 98 | Leukocytosis (HP:0001974) | 2.27792016 |
| 99 | Abnormality of macrophages (HP:0004311) | 2.27624623 |
| 100 | Myopathic facies (HP:0002058) | 2.25915592 |
| 101 | EMG: neuropathic changes (HP:0003445) | 2.24720294 |
| 102 | Abnormality of T cell physiology (HP:0011840) | 2.24124120 |
| 103 | Prolonged bleeding time (HP:0003010) | 2.23465967 |
| 104 | Muscle fiber inclusion bodies (HP:0100299) | 2.23284224 |
| 105 | Recurrent sinusitis (HP:0011108) | 2.23280985 |
| 106 | Adrenal overactivity (HP:0002717) | 2.22138754 |
| 107 | Encephalitis (HP:0002383) | 2.19731145 |
| 108 | Ulnar deviation of the wrist (HP:0003049) | 2.19709941 |
| 109 | Areflexia of lower limbs (HP:0002522) | 2.19083387 |
| 110 | Nasal polyposis (HP:0100582) | 2.18176492 |
| 111 | Spontaneous hematomas (HP:0007420) | 2.17639921 |
| 112 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.16793429 |
| 113 | Atrioventricular block (HP:0001678) | 2.16161152 |
| 114 | Granulocytopenia (HP:0001913) | 2.16154850 |
| 115 | Nemaline bodies (HP:0003798) | 2.15150413 |
| 116 | * Hyponatremia (HP:0002902) | 2.14941495 |
| 117 | Abnormality of the nasal mucosa (HP:0000433) | 2.14872416 |
| 118 | Ulnar bowing (HP:0003031) | 2.13143792 |
| 119 | Cerebral aneurysm (HP:0004944) | 2.12934336 |
| 120 | Epistaxis (HP:0000421) | 2.12924328 |
| 121 | Ragged-red muscle fibers (HP:0003200) | 2.12786881 |
| 122 | Subaortic stenosis (HP:0001682) | 2.10757214 |
| 123 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.10757214 |
| 124 | Dislocated radial head (HP:0003083) | 2.08430110 |
| 125 | Obstructive lung disease (HP:0006536) | 2.07519048 |
| 126 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07519048 |
| 127 | Abnormality of potassium homeostasis (HP:0011042) | 2.07380888 |
| 128 | Periodontitis (HP:0000704) | 2.06720790 |
| 129 | Large eyes (HP:0001090) | 2.06237394 |
| 130 | Rib fusion (HP:0000902) | 2.05297447 |
| 131 | Frequent falls (HP:0002359) | 2.03692022 |
| 132 | Lymphoma (HP:0002665) | 2.03187324 |
| 133 | Progressive external ophthalmoplegia (HP:0000590) | 2.02345007 |
| 134 | Bulbar palsy (HP:0001283) | 2.02194503 |
| 135 | Hypercalciuria (HP:0002150) | 2.01741012 |
| 136 | Hypoplasia of the thymus (HP:0000778) | 2.00964352 |
| 137 | Abnormal number of erythroid precursors (HP:0012131) | 1.97827546 |
| 138 | Facial hemangioma (HP:0000329) | 1.97470560 |
| 139 | Dysostosis multiplex (HP:0000943) | 1.97318710 |
| 140 | Myotonia (HP:0002486) | 1.95487732 |
| 141 | IgA deficiency (HP:0002720) | 1.94896510 |
| 142 | Chest pain (HP:0100749) | 1.93909825 |
| 143 | Hyperlipoproteinemia (HP:0010980) | 1.93639210 |
| 144 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.93488313 |
| 145 | Joint stiffness (HP:0001387) | 1.92301172 |
| 146 | Dyschromatopsia (HP:0007641) | 1.91184551 |
| 147 | Hypochromic anemia (HP:0001931) | 1.90767552 |
| 148 | Viral hepatitis (HP:0006562) | 1.89577605 |
| 149 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.88745656 |
| 150 | Rectal fistula (HP:0100590) | 1.88612428 |
| 151 | Rectovaginal fistula (HP:0000143) | 1.88612428 |
| 152 | Osteomyelitis (HP:0002754) | 1.88424793 |
| 153 | Oligomenorrhea (HP:0000876) | 1.88176122 |
| 154 | Autoimmune hemolytic anemia (HP:0001890) | 1.87861955 |
| 155 | Abnormality of the radial head (HP:0003995) | 1.87060507 |
| 156 | Polygenic inheritance (HP:0010982) | 1.85911123 |
| 157 | Abnormality of the prostate (HP:0008775) | 1.83482750 |
| 158 | Hyperuricemia (HP:0002149) | 1.83431999 |
| 159 | Increased purine levels (HP:0004368) | 1.83431999 |
| 160 | * Dehydration (HP:0001944) | 1.83383754 |
| 161 | Malignant hyperthermia (HP:0002047) | 1.83191107 |
| 162 | Heart block (HP:0012722) | 1.83175379 |
| 163 | Basal cell carcinoma (HP:0002671) | 1.82684732 |
| 164 | Abnormal atrioventricular conduction (HP:0005150) | 1.82465772 |
| 165 | Spinal cord lesions (HP:0100561) | 1.80398981 |
| 166 | Syringomyelia (HP:0003396) | 1.80398981 |
| 167 | Hypercortisolism (HP:0001578) | 1.78584075 |
| 168 | Abnormality of the intrinsic pathway (HP:0010989) | 1.77463416 |
| 169 | Polycythemia (HP:0001901) | 1.76858537 |
| 170 | Hematochezia (HP:0002573) | 1.76675790 |
| 171 | Vaginal fistula (HP:0004320) | 1.74546374 |
| 172 | Gingivitis (HP:0000230) | 1.74088969 |
| 173 | Sudden death (HP:0001699) | 1.72555750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.78543350 |
| 2 | WNK3 | 4.10058299 |
| 3 | PRPF4B | 3.62420987 |
| 4 | TXK | 3.05533907 |
| 5 | TRIB3 | 2.90735686 |
| 6 | GRK6 | 2.75003521 |
| 7 | ZAP70 | 2.38288899 |
| 8 | MAPK15 | 2.36246546 |
| 9 | STK10 | 2.31072819 |
| 10 | TTN | 2.28855588 |
| 11 | TGFBR2 | 2.22292796 |
| 12 | OXSR1 | 2.20406312 |
| 13 | JAK3 | 2.16511610 |
| 14 | ITK | 2.15710209 |
| 15 | KIT | 2.10524905 |
| 16 | MST4 | 2.10035674 |
| 17 | IKBKE | 2.06970011 |
| 18 | BTK | 2.05730340 |
| 19 | MAPK12 | 1.92780502 |
| 20 | IRAK4 | 1.80750807 |
| 21 | PRKD2 | 1.79007257 |
| 22 | BLK | 1.78647105 |
| 23 | TYK2 | 1.78434496 |
| 24 | MAP3K10 | 1.75559746 |
| 25 | TEC | 1.74332254 |
| 26 | MAP3K14 | 1.73955380 |
| 27 | SYK | 1.72091882 |
| 28 | SIK1 | 1.68301839 |
| 29 | IRAK3 | 1.58976832 |
| 30 | WNK4 | 1.58944717 |
| 31 | TBK1 | 1.57898896 |
| 32 | STK38 | 1.57687638 |
| 33 | NME2 | 1.51118730 |
| 34 | LCK | 1.50633391 |
| 35 | NLK | 1.49249100 |
| 36 | MAP3K13 | 1.47237335 |
| 37 | FGFR4 | 1.43528220 |
| 38 | RIPK4 | 1.38655770 |
| 39 | CSK | 1.38243079 |
| 40 | TESK2 | 1.37683963 |
| 41 | SMG1 | 1.37280885 |
| 42 | CSF1R | 1.36762014 |
| 43 | PIM1 | 1.31113446 |
| 44 | LRRK2 | 1.30454638 |
| 45 | SIK2 | 1.26859506 |
| 46 | MOS | 1.26139561 |
| 47 | CLK1 | 1.25453413 |
| 48 | HCK | 1.24589503 |
| 49 | TSSK6 | 1.22582507 |
| 50 | FES | 1.22520306 |
| 51 | MAP2K3 | 1.21914172 |
| 52 | EEF2K | 1.18666137 |
| 53 | MAPK7 | 1.17676579 |
| 54 | KDR | 1.14219895 |
| 55 | JAK1 | 1.13398675 |
| 56 | LYN | 1.10905210 |
| 57 | TLK1 | 1.10811381 |
| 58 | TAOK3 | 1.10772133 |
| 59 | ERN1 | 1.09734283 |
| 60 | IKBKB | 1.05238789 |
| 61 | RIPK1 | 1.04094528 |
| 62 | CDC42BPA | 1.03857629 |
| 63 | OBSCN | 1.00738964 |
| 64 | PIK3CG | 1.00513982 |
| 65 | TAOK1 | 0.98589216 |
| 66 | PKN2 | 0.97277528 |
| 67 | SGK2 | 0.96836608 |
| 68 | SGK3 | 0.95142473 |
| 69 | FLT3 | 0.92195372 |
| 70 | MAP3K3 | 0.90452314 |
| 71 | TRPM7 | 0.89702080 |
| 72 | PDPK1 | 0.88646217 |
| 73 | PRKAA2 | 0.82670131 |
| 74 | IRAK2 | 0.82109161 |
| 75 | FGFR3 | 0.81132612 |
| 76 | ICK | 0.79621324 |
| 77 | MAP3K7 | 0.79375680 |
| 78 | EIF2AK1 | 0.77016067 |
| 79 | TGFBR1 | 0.76101212 |
| 80 | MARK3 | 0.75679267 |
| 81 | RPS6KA4 | 0.75169796 |
| 82 | TAOK2 | 0.74391586 |
| 83 | EPHB2 | 0.74037893 |
| 84 | EPHB1 | 0.73689577 |
| 85 | GRK5 | 0.73230748 |
| 86 | RPS6KL1 | 0.72707698 |
| 87 | RPS6KC1 | 0.72707698 |
| 88 | JAK2 | 0.71888424 |
| 89 | MTOR | 0.70784936 |
| 90 | HIPK2 | 0.70402124 |
| 91 | RPS6KA2 | 0.70287573 |
| 92 | MAP3K1 | 0.69668006 |
| 93 | RPS6KA6 | 0.65978217 |
| 94 | WNK1 | 0.64319088 |
| 95 | CDK4 | 0.64180858 |
| 96 | MAP3K11 | 0.63255753 |
| 97 | SIK3 | 0.62014958 |
| 98 | CAMK4 | 0.60064421 |
| 99 | CHUK | 0.59641886 |
| 100 | PRKCQ | 0.58193728 |
| 101 | MAP3K6 | 0.53497638 |
| 102 | MAPK11 | 0.53424782 |
| 103 | PDK1 | 0.52292236 |
| 104 | CAMK1D | 0.51726988 |
| 105 | YES1 | 0.50523780 |
| 106 | TNK2 | 0.49662451 |
| 107 | CAMK1 | 0.47880698 |
| 108 | SGK494 | 0.46108385 |
| 109 | SGK223 | 0.46108385 |
| 110 | DYRK3 | 0.45429095 |
| 111 | DYRK1B | 0.43878034 |
| 112 | STK11 | 0.42976494 |
| 113 | STK4 | 0.42419613 |
| 114 | CDK9 | 0.41862973 |
| 115 | PRKAA1 | 0.39992259 |
| 116 | CDK6 | 0.39164301 |
| 117 | MAPK8 | 0.39022910 |
| 118 | ACVR1B | 0.38697030 |
| 119 | MAP2K6 | 0.38008349 |
| 120 | MAPK4 | 0.37891067 |
| 121 | RET | 0.35624872 |
| 122 | MAPK3 | 0.35510142 |
| 123 | PDGFRB | 0.35426875 |
| 124 | CDK12 | 0.35403274 |
| 125 | ABL1 | 0.35381559 |
| 126 | KSR2 | 0.35129647 |
| 127 | MARK2 | 0.33448685 |
| 128 | PRKCD | 0.31823070 |
| 129 | BCKDK | 0.31785570 |
| 130 | NEK2 | 0.31448464 |
| 131 | PRKCH | 0.30232775 |
| 132 | MATK | 0.29228290 |
| 133 | VRK1 | 0.28744071 |
| 134 | PRKD1 | 0.27624091 |
| 135 | CDK19 | 0.23580559 |
| 136 | NEK9 | 0.23349680 |
| 137 | GRK7 | 0.23334801 |
| 138 | PTK6 | 0.23230837 |
| 139 | NUAK1 | 0.22666683 |
| 140 | MAPKAPK2 | 0.22644341 |
| 141 | PAK4 | 0.22097010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.95999265 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.03515284 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.90039690 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.81939775 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.66595526 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.61081031 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.49925927 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.45135709 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.41667753 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.23661358 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.07786121 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.06714807 |
| 13 | Ribosome_Homo sapiens_hsa03010 | 1.94027799 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92847266 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90261096 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.89973829 |
| 17 | DNA replication_Homo sapiens_hsa03030 | 1.80946469 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61154358 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.58961840 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58820844 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.57289022 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54533080 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49876794 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.49755269 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.49725200 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48645354 |
| 27 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.38668991 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36221443 |
| 29 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.33688651 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.33628965 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32264492 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27023537 |
| 33 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.26360846 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26220338 |
| 35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.25013117 |
| 36 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.22362337 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.21236875 |
| 38 | Lysine degradation_Homo sapiens_hsa00310 | 1.20184686 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19889096 |
| 40 | Mismatch repair_Homo sapiens_hsa03430 | 1.17683220 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17009829 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16797251 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16460544 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.16304630 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15889229 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14077169 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.13891122 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.13490209 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10231286 |
| 50 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.08478951 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 1.07729819 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 1.07017869 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05998132 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04796917 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 1.04425052 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03030970 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.02109481 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 1.02022332 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00463321 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00160413 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93930511 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93743227 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90919088 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.90883153 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.90705125 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90635366 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89145739 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88706491 |
| 69 | Spliceosome_Homo sapiens_hsa03040 | 0.88603648 |
| 70 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.85991470 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81957064 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.81439271 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80775617 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.80767388 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79786917 |
| 76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79495989 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.78108770 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77929478 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76587833 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76565098 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74776812 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73094857 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72480811 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72332071 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71919287 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71562946 |
| 87 | Homologous recombination_Homo sapiens_hsa03440 | 0.71040604 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69694097 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69675172 |
| 90 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69467617 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69317072 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68871274 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67538123 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67387481 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66197040 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66134300 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63750291 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63579067 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62520426 |
| 100 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.61050752 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60802168 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60781182 |
| 103 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.59874660 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59865750 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59699528 |
| 106 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59331586 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.58153691 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57778038 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57639109 |
| 110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57224034 |
| 111 | Asthma_Homo sapiens_hsa05310 | 0.56894542 |
| 112 | Glioma_Homo sapiens_hsa05214 | 0.56533361 |
| 113 | Long-term potentiation_Homo sapiens_hsa04720 | 0.54966636 |
| 114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53981324 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.53762268 |
| 116 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53314596 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49261224 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48809882 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46847816 |
| 120 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44954879 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44687860 |
| 122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44256241 |
| 123 | Malaria_Homo sapiens_hsa05144 | 0.41107492 |
| 124 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40949763 |
| 125 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40777502 |
| 126 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.40468571 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40038910 |
| 128 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39296109 |
| 129 | Peroxisome_Homo sapiens_hsa04146 | 0.38407988 |
| 130 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.35703030 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34171577 |
| 132 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33051649 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.32183987 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30267951 |
| 135 | Endocytosis_Homo sapiens_hsa04144 | 0.29978836 |
| 136 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28905865 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.28319168 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28132043 |
| 139 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.28025479 |

